Fidia farmaceutici, part of Fidia Pharma Group, is an Italian multinational developer and leading manufacturer (inspected and approved by major international health authorities) of innovative products mainly based on hyaluronic acid (700+ patents), in joint care, wound healing, ophthalmology, aesthetic and regenerative medicine. Products are available in 100 countries worldwide, through wholly-owned subsidiaries and commercial partners. The Company has entered the medical aesthetic market with a new line of hyaluronic acid-based products, thereby responding to ever wider needs of innovative, safe and effective solutions for skin wellness and beauty, and the most advanced treatment protocols available to the aesthetic doctor, which preserve the person’s unique identity. More recently, Fidia Pharma Group has announced the expansion of its Aesthetic Medicine portfolio and entry into the Regenerative Medicine market, with innovative technologies.